Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Cancer Therapy Reviews
  4. Fast Track Articles
  5. Fast Track Article
image of Long Non-coding RNAs: Potential Diagnostic and Treatment Targets for Non-small Cell Lung Cancer

Abstract

Lung cancer is the leading cause of cancer-related deaths globally, necessitating ongoing scientific research to understand its detection, treatment, and prevention. Long non-coding RNAs (lncRNAs) are a diverse group of non-coding RNAs that play crucial roles in regulating tumorigenic processes, such as cell proliferation, invasion, and metastasis in non-small cell lung cancer (NSCLC). Despite not encoding proteins, lncRNAs have significant impacts on the development and progression of NSCLC. Recent evidence suggests that lncRNAs may serve as valuable biomarkers for diagnosing and prognosticating NSCLC through tissue or blood analysis, and as potential therapeutic targets. This review provides a comprehensive overview of recent advancements in lncRNA research for NSCLC, offering new insights into their mechanisms of action and potential therapeutic applications. It also explores promising avenues for therapeutic development. By elucidating the complex roles of lncRNAs in NSCLC, this article aims to contribute to the development of innovative diagnostic and therapeutic strategies that can significantly enhance patient outcomes. Understanding the multifaceted functions of lncRNAs in lung cancer has the potential to lead to substantial progress in early disease detection, targeted treatments, and personalized medicine, ultimately improving the prognosis and quality of life for individuals affected by this devastating disease.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cctr/10.2174/0115733947339431241001080157
2024-10-11
2024-11-23

  • From This Site

    /content/journals/cctr/10.2174/0115733947339431241001080157
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Bray F. Laversanne M. Sung H. Ferlay J. Siegel R.L. Soerjomataram I. Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2024 74 3 229 263 10.3322/caac.21834 38572751
    [Google Scholar]
  2. Beermann J. Piccoli M.T. Viereck J. Thum T. Non-coding RNAs in development and disease: Background, mechanisms, and therapeutic approaches. Physiol. Rev. 2016 96 4 1297 1325 10.1152/physrev.00041.2015 27535639
    [Google Scholar]
  3. Hong D. Xu K. Zhang L. Wan X. Guo Y. Radiomics signature as a predictive factor for EGFR mutations in advanced lung adenocarcinoma. Front. Oncol. 2020 10 28 10.3389/fonc.2020.00028 32082997
    [Google Scholar]
  4. Huang J. Pan B. Xia G. Zhu J. Li C. Feng J. LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1. Cell Death Dis. 2020 11 7 525 525 10.1038/s41419‑020‑2683‑x 32655137
    [Google Scholar]
  5. Quinn J.J. Chang H.Y. Unique features of long non-coding RNA biogenesis and function. Nat. Rev. Genet. 2016 17 1 47 62 10.1038/nrg.2015.10 26666209
    [Google Scholar]
  6. Zhang Y. Dong X. Guo X. Li C. Fan Y. Liu P. Yuan D. Ma X. Wang J. Zheng J. Li H. Gao P. LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer. Mol. Cancer 2023 22 1 41 41 10.1186/s12943‑023‑01747‑5 36859185
    [Google Scholar]
  7. Mattick J.S. Amaral P.P. Carninci P. Carpenter S. Chang H.Y. Chen L.L. Chen R. Dean C. Dinger M.E. Fitzgerald K.A. Gingeras T.R. Guttman M. Hirose T. Huarte M. Johnson R. Kanduri C. Kapranov P. Lawrence J.B. Lee J.T. Mendell J.T. Mercer T.R. Moore K.J. Nakagawa S. Rinn J.L. Spector D.L. Ulitsky I. Wan Y. Wilusz J.E. Wu M. Long non-coding RNAs: Definitions, functions, challenges and recommendations. Nat. Rev. Mol. Cell Biol. 2023 24 6 430 447 10.1038/s41580‑022‑00566‑8 36596869
    [Google Scholar]
  8. Gencel-Augusto J. Wu W. Bivona T.G. Long non-coding RNAs as emerging targets in lung cancer. Cancers 2023 15 12 3135 10.3390/cancers15123135 37370745
    [Google Scholar]
  9. Zhang R. Xia Y. Wang Z. Zheng J. Chen Y. Li X. Wang Y. Ming H. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer. Biochem. Biophys. Res. Commun. 2017 490 2 406 414 10.1016/j.bbrc.2017.06.055 28623135
    [Google Scholar]
  10. Li N. Wang Y. Liu X. Luo P. Jing W. Zhu M. Tu J. Identification of circulating long noncoding RNA HOTAIR as a novel biomarker for diagnosis and monitoring of non–small cell lung cancer. Technol. Cancer Res. Treat. 2017 16 6 1060 1066 10.1177/1533034617723754 28784052
    [Google Scholar]
  11. Guo D. Wang Y. Ren K. Han X. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression. Exp. Cell Res. 2018 362 1 172 179 10.1016/j.yexcr.2017.11.014 29133127
    [Google Scholar]
  12. Gao J. Pan T. Wang H. Wang S. Chai J. Jin C. LncRNA FAM138B inhibits the progression of non-small cell lung cancer through miR-105-5p. Cell Cycle 2023 22 7 808 817 10.1080/15384101.2022.2154556 36529892
    [Google Scholar]
  13. Ponting C.P. Oliver P.L. Reik W. Evolution and functions of long noncoding RNAs. Cell 2009 136 4 629 641 10.1016/j.cell.2009.02.006 19239885
    [Google Scholar]
  14. Ransohoff J.D. Wei Y. Khavari P.A. The functions and unique features of long intergenic non-coding RNA. Nat. Rev. Mol. Cell Biol. 2018 19 3 143 157 10.1038/nrm.2017.104 29138516
    [Google Scholar]
  15. Yarmishyn A.A. Kurochkin I.V. Long noncoding RNAs: A potential novel class of cancer biomarkers. Front. Genet. 2015 6 145 145 10.3389/fgene.2015.00145 25954300
    [Google Scholar]
  16. Pennisi E. Genomics. ENCODE project writes eulogy for junk DNA. Science 2012 337 6099 1159 1161, 1161 10.1126/science.337.6099.1159 22955811
    [Google Scholar]
  17. Xiang J.F. Yin Q.F. Chen T. Zhang Y. Zhang X.O. Wu Z. Zhang S. Wang H.B. Ge J. Lu X. Yang L. Chen L.L. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Cell Res. 2014 24 5 513 531 10.1038/cr.2014.35 24662484
    [Google Scholar]
  18. Melton C. Reuter J.A. Spacek D.V. Snyder M. Recurrent somatic mutations in regulatory regions of human cancer genomes. Nat. Genet. 2015 47 7 710 716 10.1038/ng.3332 26053494
    [Google Scholar]
  19. Yuan Q. Chu H. Ge Y. Ma G. Du M. Wang M. Zhang Z. Zhang W. LncRNA PCAT1 and its genetic variant rs1902432 are associated with prostate cancer risk. J. Cancer 2018 9 8 1414 1420 10.7150/jca.23685 29721051
    [Google Scholar]
  20. Ji P. Diederichs S. Wang W. Böing S. Metzger R. Schneider P.M. Tidow N. Brandt B. Buerger H. Bulk E. Thomas M. Berdel W.E. Serve H. Müller-Tidow C. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003 22 39 8031 8041 10.1038/sj.onc.1206928 12970751
    [Google Scholar]
  21. Flynn R.A. Chang H.Y. Long noncoding RNAs in cell-fate programming and reprogramming. Cell Stem Cell 2014 14 6 752 761 10.1016/j.stem.2014.05.014 24905165
    [Google Scholar]
  22. Yang Z. Xu F. Teschendorff A.E. Zhao Y. Yao L. Li J. He Y. Insights into the role of long non-coding RNAs in DNA methylation mediated transcriptional regulation. Front. Mol. Biosci. 2022 9 1067406 10.3389/fmolb.2022.1067406 36533073
    [Google Scholar]
  23. Zhu C. Wang X. Wang Y. Wang K. Functions and underlying mechanisms of lncRNA HOTAIR in cancer chemotherapy resistance. Cell Death Discov. 2022 8 1 383 10.1038/s41420‑022‑01174‑3 36100611
    [Google Scholar]
  24. Bhan A. Mandal S.S. LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer. Biochimica et Biophysica Acta (BBA)-. Revis. Cancer 2015 1856 1 151 164
    [Google Scholar]
  25. Majello B. Gorini F. Saccà C.D. Amente S. Expanding the role of the histone lysine-specific demethylase LSD1 in cancer. Cancers 2019 11 3 324 10.3390/cancers11030324 30866496
    [Google Scholar]
  26. Jang W. Im M. Roh J. Kang J.H. Kim W. Hippo-YAP/TAZ pathway regulation: The crucial roles of lncRNAs in cancer. Anim. Cells Syst. 2023 27 1 309 320 10.1080/19768354.2023.2281370
    [Google Scholar]
  27. Peña-Flores J.A. Enríquez-Espinoza D. Muela-Campos D. Álvarez-Ramírez A. Sáenz A. Barraza-Gómez A.A. Bravo K. Estrada-Macías M.E. González-Alvarado K. Functional relevance of the long intergenic non-coding RNA regulator of reprogramming (Linc-ROR) in cancer proliferation, metastasis, and drug resistance. Noncoding RNA 2023 9 1 12 10.3390/ncrna9010012 36827545
    [Google Scholar]
  28. Song H. Chen L. Liu W. Xu X. Zhou Y. Zhu J. Chen X. Li Z. Zhou H. Depleting long noncoding RNA HOTAIR attenuates chronic myelocytic leukemia progression by binding to DNA methyltransferase 1 and inhibiting PTEN gene promoter methylation. Cell Death Dis. 2021 12 5 440 10.1038/s41419‑021‑03637‑4 33941772
    [Google Scholar]
  29. Gibney E.R. Nolan C.M. Epigenetics and gene expression. Heredity 2010 105 1 4 13 10.1038/hdy.2010.54 20461105
    [Google Scholar]
  30. Xue W. Zheng Y. Shen Z. Li L. Fan Z. Wang W. Zhu Z. Zhai Y. Zhao J. Kan Q. Involvement of long non‐coding RNAs in the progression of esophageal cancer. Cancer Commun. 2021 41 5 371 388 10.1002/cac2.12146 33605567
    [Google Scholar]
  31. Miao H. Wang L. Zhan H. Dai J. Chang Y. Wu F. Liu T. Liu Z. Gao C. Li L. Song X. A long noncoding RNA distributed in both nucleus and cytoplasm operates in the PYCARD-regulated apoptosis by coordinating the epigenetic and translational regulation. PLoS Genet. 2019 15 5 e1008144 10.1371/journal.pgen.1008144 31086376
    [Google Scholar]
  32. Wang Y. Liang S. Yu Y. Shi Y. Zheng H. Knockdown of SNHG12 suppresses tumor metastasis and epithelial-mesenchymal transition via the Slug/ZEB2 signaling pathway by targeting miR-218 in NSCLC. Oncol. Lett. 2019 17 2 2356 2364 30719111
    [Google Scholar]
  33. Wang X. Qi G. Zhang J. Wu J. Zhou N. Li L. Ma J. Knockdown of long noncoding RNA small nucleolar rna host gene 12 inhibits cell growth and induces apoptosis by upregulating mir-138 in nonsmall cell lung cancer. DNA Cell Biol. 2017 36 11 892 900 10.1089/dna.2017.3830 28872894
    [Google Scholar]
  34. Li S. Chen X. Liu X. Yu Y. Pan H. Haak R. Schmidt J. Ziebolz D. Schmalz G. Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma. Oral Oncol. 2017 73 1 9 10.1016/j.oraloncology.2017.07.026 28939059
    [Google Scholar]
  35. Aftabi Y. Ansarin K. Shanehbandi D. Khalili M. Seyedrezazadeh E. Rahbarnia L. Asadi M. Amiri-Sadeghan A. Zafari V. Eyvazi S. Bakhtiyari N. Zarredar H. Long non‐coding RNAs as potential biomarkers in the prognosis and diagnosis of lung cancer: A review and target analysis. IUBMB Life 2021 73 2 307 327 10.1002/iub.2430 33369006
    [Google Scholar]
  36. Yang Y-R. Zang S-Z. Zhong C-L. Li Y-X. Zhao S-S. Feng X-J. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Int. J. Clin. Exp. Pathol. 2014 7 10 6929 6935 25400777
    [Google Scholar]
  37. Wu D. Li Y. Zhang H. Hu X. Knockdown of Lncrna PVT1 enhances radiosensitivity in non-small cell lung cancer by sponging Mir-195. Cell. Physiol. Biochem. 2017 42 6 2453 2466 10.1159/000480209 28848163
    [Google Scholar]
  38. Zhang Y. Li X. Hou Y. Fang N. You J. Zhou Q. The lncRNA XIST exhibits oncogenic properties via regulation of miR-449a and Bcl-2 in human non-small cell lung cancer. Acta Pharmacol. Sin. 2017 38 3 371 381 10.1038/aps.2016.133 28248928
    [Google Scholar]
  39. Zhou X. Xu X. Gao C. Cui Y. XIST promote the proliferation and migration of non-small cell lung cancer cells via sponging miR-16 and regulating CDK8 expression. Am. J. Transl. Res. 2019 11 9 6196 6206 31632587
    [Google Scholar]
  40. Roh J. Kim B. Im M. Jang W. Chae Y. Kang J. Youn B. Kim W. MALAT1-regulated gene expression profiling in lung cancer cell lines. BMC Cancer 2023 23 1 818 818 10.1186/s12885‑023‑11347‑7 37667226
    [Google Scholar]
  41. Yang Geng Pengfei Chen Lei Zhang Xiaojun Li Chao Song Xueting Wei Huiyuan Gong LncRNA MALAT1 regulates growth of carcinoma of the lung through modulating miR-338-3p/PYCR2 axis. Cell. Mol. Biol. 2023 69 4 133 140 10.14715/cmb/2023.69.4.21 37329534
    [Google Scholar]
  42. Liu C. Li H. Jia J. Ruan X. Liu Y. Zhang X. High metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) expression promotes proliferation, migration, and invasion of non-small cell lung cancer via ERK/mitogen-activated protein kinase (MAPK) signaling pathway. Med. Sci. Monit. 2019 25 5143 5149 10.12659/MSM.913308 31293277
    [Google Scholar]
  43. Ying Sun Liming Fan Yixian Li Low expression of LncRNA AFAP1-AS1 inhibits proliferation and promotes apoptosis of non-small cell lung cancer cells through inhibiting wnt signaling pathway. Cell. Mol. Biol. 2023 69 12 176 180 10.14715/cmb/2023.69.12.28 38063100
    [Google Scholar]
  44. Li H. Cui Z. Lv X. Li J. Gao M. Yang Z. Bi Y. Zhang Z. Wang S. Li S. Zhou B. Yin Z. Long non-coding RNA HOTAIR function as a competing endogenous RNA for miR-149-5p to promote the cell growth, migration, and invasion in non-small cell lung cancer. Front. Oncol. 2020 10 528520 528520 10.3389/fonc.2020.528520 33102210
    [Google Scholar]
  45. Lu K. Li W. Liu X. Sun M. Zhang M. Wu W. Xie W. Hou Y. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer 2013 13 1 461 461 10.1186/1471‑2407‑13‑461 24098911
    [Google Scholar]
  46. Lv D. Bi Q. Li Y. Deng J. Wu N. Hao S. Zhao M. Long non‑coding RNA MEG3 inhibits cell migration and invasion of non‑small cell lung cancer cells by regulating the miR‑21‑5p/PTEN axis. Mol. Med. Rep. 2021 23 3 191 10.3892/mmr.2021.11830 33495842
    [Google Scholar]
  47. Shi X. Sun M. Liu H. Yao Y. Kong R. Chen F. Song Y. A critical role for the long non‐coding RNA GAS5 in proliferation and apoptosis in non‐small‐cell lung cancer. Mol. Carcinog. 2015 54 S1 Suppl. 1 E1 E12 10.1002/mc.22120 24357161
    [Google Scholar]
  48. Xu W.N. Zheng H.L. Yang R.Z. Liu T. Yu W. Zheng X.F. Li B. Jiang S.D. Jiang L.S. Mitochondrial NDUFA4L2 attenuates the apoptosis of nucleus pulposus cells induced by oxidative stress via the inhibition of mitophagy. Exp. Mol. Med. 2019 51 11 1 16 10.1038/s12276‑019‑0331‑2 31740659
    [Google Scholar]
  49. Yang X. Meng L. Zhong Y. Hu F. Wang L. Wang M. The long intergenic noncoding RNA GAS5 reduces cisplatin-resistance in non-small cell lung cancer through the miR-217/LHPP axis. Aging 2021 13 2 2864 2884 10.18632/aging.202352 33418541
    [Google Scholar]
  50. Shen Q. Wang H. Zhang L. TP63 functions as a tumor suppressor regulated by GAS5/miR-221-3p signaling axis in human non-small cell lung cancer cells. Cancer Manag. Res. 2023 15 217 231 10.2147/CMAR.S387781 36873253
    [Google Scholar]
  51. Fu Y. Liu L. Wu H. Zheng Y. Zhan H. Li L. LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis. Mol. Cell. Biochem. 2024 479 3 553 566 10.1007/s11010‑023‑04748‑6 37120495
    [Google Scholar]
  52. Jiang N. Zhang X. Gu X. Li X. Shang L. Progress in understanding the role of lncRNA in programmed cell death. Cell Death Discov. 2021 7 1 30 30 10.1038/s41420‑021‑00407‑1 33558499
    [Google Scholar]
  53. Wang R.Q. Long X.R. Zhou N.N. Chen D.N. Zhang M.Y. Wen Z.S. Zhang L.J. He F.Z. Zhou Z.L. Mai S.J. Wang H.Y. Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging mir-26a-5p to activate PTEN signaling in non-small cell lung cancer. J. Exp. Clin. Cancer Res. 2021 40 1 9 9 10.1186/s13046‑020‑01819‑0 33407724
    [Google Scholar]
  54. Han B. LncRNA LINC02418 regulates proliferation and apoptosis of non-small cell lung cancer cells by regulating miR-4677-3p/SEC61G. Eur. Rev. Med. Pharmacol. Sci. 2019 23 23 10354 10362 31841189
    [Google Scholar]
  55. Wang T. Tang X. Liu Y. LncRNA-ATB promotes apoptosis of non-small cell lung cancer cells through MiR-200a/β-Catenin. JBUON 2019 24 6 2280 2286 31983095
    [Google Scholar]
  56. Wu J. Huang X. Li X. Zhou H. Chen X. Chen Y. Guo Y. Huang J. Huang H. Huang Z. Chen G. Yang Z. Zhang J. Su W. Suppression of the long non-coding RNA LINC01279 triggers autophagy and apoptosis in lung cancer by regulating FAK and SIN3A. Discov. Oncol. 2024 15 1 3 3 10.1007/s12672‑023‑00855‑4 38168833
    [Google Scholar]
  57. Moyer V.A. U.S. Preventive Services Task Force Screening for oral cancer: U.S. Preventive services task force recommendation statement. Ann. Intern. Med. 2014 160 1 55-60 10.7326/M13‑2568 24276469
    [Google Scholar]
  58. Aberle D.R. Adams A.M. Berg C.D. Black W.C. Clapp J.D. Fagerstrom R.M. Gareen I.F. Gatsonis C. Marcus P.M. Sicks J.D. National Lung Screening Trial Research Team Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 2011 365 5 395 409 10.1056/NEJMoa1102873 21714641
    [Google Scholar]
  59. Ye R. Tang R. Gan S. Li R. Cheng Y. Guo L. Zeng C. Sun Y. New insights into long non-coding RNAs in non-small cell lung cancer. Biomed. Pharmacother. 2020 131 110775 10.1016/j.biopha.2020.110775 33152934
    [Google Scholar]
  60. Wang N. Yao C. Luo C. Liu S. Wu L. Hu W. Zhang Q. Rong Y. Yuan C. Wang F. Integrated plasma and exosome long noncoding RNA profiling is promising for diagnosing non-small cell lung cancer. Clin. Chem. Lab. Med. 2023 61 12 2216 2228 10.1515/cclm‑2023‑0291 37387637
    [Google Scholar]
  61. Vesovic N. Tosic N. Karan Djurasevic T. Andric Z. Zdravkovic D. Pavlovic S. Jovanovic D. Expression pattern of circulating long non-coding RNA GAS5 as a novel biomarker in non-small cell lung cancer patients. Arch. Med. Sci. 2020 10.5114/aoms.2020.98815
    [Google Scholar]
  62. Xie Y. Zhang Y. Du L. Jiang X. Yan S. Duan W. Li J. Zhan Y. Wang L. Zhang S. Li S. Wang L. Xu S. Wang C. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non‐small cell lung cancer. Mol. Oncol. 2018 12 5 648 658 10.1002/1878‑0261.12188 29504701
    [Google Scholar]
  63. Li Z. Zhuo Y. Li J. Zhang M. Wang R. Lin L. Long non-coding RNA SNHG4 is a potential diagnostic and prognostic indicator in non-small cell lung cancer. Ann. Clin. Lab. Sci. 2021 51 5 654 662 34686507
    [Google Scholar]
  64. Xiao T. Yan A. Tan L. Zhu H. Gao W. LncRNA HOXA‑AS2 is a prognostic and clinicopathological predictor in patients with cancer: A meta‑analysis. Oncol. Lett. 2024 27 5 226 226 10.3892/ol.2024.14359 38586205
    [Google Scholar]
  65. Ma X. Chen Z. Chen W. Chen Z. Shang Y. Zhao Y. Li L. Zhou C. He J. Meng X. LncRNA AL139294.1 can be transported by extracellular vesicles to promote the oncogenic behaviour of recipient cells through activation of the Wnt and NF-κB2 pathways in non-small-cell lung cancer. J. Exp. Clin. Cancer Res. 2024 43 1 20 10.1186/s13046‑023‑02939‑z 38229152
    [Google Scholar]
  66. Li J. Li Y. Sun X. Wei L. Guan J. Fu L. Du J. Zhang X. Cheng M. Ma H. Jiang S. Zheng Q. Wang L. Silencing lncRNA‐DARS‐AS1 suppresses nonsmall cell lung cancer progression by stimulating miR‐302a‐3p to inhibit ACAT1 expression. Mol. Carcinog. 2024 63 4 757 771 10.1002/mc.23686 38289172
    [Google Scholar]
  67. Miao X. Xi W. Bao Y. LncRNA RP11-58O9.2 predicts poor prognosis and promotes progression of non-small cell lung cancer. J. Int. Med. Res. 2023 51 10 03000605231206295 10.1177/03000605231206295 37871619
    [Google Scholar]
  68. Dasari S. Bernard Tchounwou P. Cisplatin in cancer therapy: Molecular mechanisms of action. Eur. J. Pharmacol. 2014 740 364 378 10.1016/j.ejphar.2014.07.025 25058905
    [Google Scholar]
  69. Florea A.M. Büsselberg D. Cisplatin as an anti-tumor drug: Cellular mechanisms of activity, drug resistance and induced side effects. Cancers 2011 3 1 1351 1371 10.3390/cancers3011351 24212665
    [Google Scholar]
  70. Wang M. Fu Y. Zhong C. Gacche R.N. Wu P. Long non-coding RNA and Evolving drug resistance in lung cancer. Heliyon 2023 9 12 e22591 e22591 10.1016/j.heliyon.2023.e22591 38089985
    [Google Scholar]
  71. Ge P. Cao L. Zheng M. Yao Y. Wang W. Chen X. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis. Exp. Mol. Pathol. 2021 120 104633 10.1016/j.yexmp.2021.104633 33753110
    [Google Scholar]
  72. She K. He S. Lu X. Yu S. Li M. Xiong W. Zhou M. LncRNA SNHG7 promotes non-small cell lung cancer progression and cisplatin resistance by inducing autophagic activity. J. Thorac. Dis. 2023 15 1 155 167 10.21037/jtd‑22‑1826 36794139
    [Google Scholar]
  73. Ma P. Han W. Meng C. Tan X. Liu P. Dong L. LINC02389/miR-7-5p regulated cisplatin resistance of non-small-cell lung cancer via promoting oxidative stress. Anal. Cell. Pathol. 2022 2022 1 13 10.1155/2022/6100176 36311891
    [Google Scholar]
  74. Gong F. Dong D. Zhang T. Xu W. Long non-coding RNA FENDRR attenuates the stemness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR. Eur. J. Pharmacol. 2019 853 345 352 10.1016/j.ejphar.2019.04.022 30981768
    [Google Scholar]
  75. Zhao Q. Wang N. Li Y. Wu Q. Wu L. Lnc-TMEM132D-AS1 overexpression reduces sensitivity of non-small cell lung cancer cells to osimertinib. J Southern Med Univ. 2023 43 2 242 250
    [Google Scholar]
  76. Shan K.Z. Yang S.F. Deng Y.J. Yue P.Y. Du Z.Q. E2F1-induced long non-coding RNA MCF2L-AS1 modulates Cyclin D1 mRNA stability through ELAVL1 to induce Gefitinib resistance in non-small cell lung cancer. Acta Biochim. Pol. 2022 69 4 795 804 10.18388/abp.2020_6118 36257058
    [Google Scholar]
  77. Wang S. Liu C. Lei Q. Wu Z. Miao X. Zhu D. Yang X. Li N. Tang M. Chen Y. Wang W. Relationship between long non-coding RNA PCAT-1 expression and gefitinib resistance in non-small-cell lung cancer cells. Respir. Res. 2021 22 1 146 146 10.1186/s12931‑021‑01719‑7 33980216
    [Google Scholar]
  78. Wang P. Chen D. Ma H. Li Y. LncRNA SNHG12 contributes to multidrug resistance through activating the MAPK/Slug pathway by sponging miR-181a in non-small cell lung cancer. Oncotarget 2017 8 48 84086 84101 10.18632/oncotarget.20475 29137407
    [Google Scholar]
  79. Zheng Y. Guo Z. Li Y. Long non-coding RNA prostate cancer-associated transcript 6 inhibited gefitinib sensitivity of non-small cell lung cancer by serving as a competing endogenous RNA of miR-326 to up-regulate interferon-alpha receptor 2. Bioengineered 2022 13 2 3785 3796 10.1080/21655979.2022.2031416 35081872
    [Google Scholar]
  80. Pan R. Zhou H. Exosomal transfer of lncRNA H19 promotes erlotinib resistance in non-small cell lung cancer via miR-615-3p/ATG7 axis. Cancer Manag. Res. 2020 12 4283 4297 10.2147/CMAR.S241095 32606925
    [Google Scholar]
  81. Zuo T. Jiang P. Fu J. Zhang Y. LncRNA AFAP1-AS1 induces gefitinib resistance of lung adenocarcinoma through the miR-653-5p/AGR2 axis. Ther. Clin. Risk Manag. 2023 19 1 13 10.2147/TCRM.S374162 36636455
    [Google Scholar]
  82. Wang N. Zhao Q. Huang Y. Wen C. Li Y. Bao M. Wu L. Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancer. Mol. Omics 2023 19 3 238 251 10.1039/D2MO00261B 36651104
    [Google Scholar]
  83. Shi T. Sun W. Shi Y-L. Wang Q. Yan Z-X. Zhang M. LncRNA OSER1-AS1 interacts with miR-612/FOXM1 axis to modulate gefitinib resistance of lung adenocarcinoma. Am. J. Transl. Res. 2021 13 3 1365 1376 33841662
    [Google Scholar]
  84. Bing Z. Han J. Zheng Z. Liang N. FOXO3-induced oncogenic lncRNA CASC9 enhances gefitinib resistance of non-small-cell lung cancer through feedback loop. Life Sci. 2021 287 120012 10.1016/j.lfs.2021.120012 34619168
    [Google Scholar]
  85. Ma G. Zhu J. Liu F. Yang Y. Long Noncoding R.N.A. Long noncoding RNA LINC00460 promotes the gefitinib resistance of nonsmall cell lung cancer through epidermal growth factor receptor by sponging miR-769-5p. DNA Cell Biol. 2019 38 2 176 183 10.1089/dna.2018.4462 30601026
    [Google Scholar]
  86. Wang Z. LncRNA CCAT1 downregulation increases the radiosensitivity of non‐small cell lung cancer cells. Kaohsiung J. Med. Sci. 2021 37 8 654 663 10.1002/kjm2.12387 33955133
    [Google Scholar]
  87. Wu A. Tang J. Dai Y. Huang H. Nie J. Hu W. Pei H. Zhou G. Downregulation of long noncoding RNA CRYBG3 enhances radiosensitivity in non-small cell lung cancer depending on p53 status. Radiat. Res. 2022 198 3 297 305 10.1667/RADE‑21‑00197.1 35439322
    [Google Scholar]
  88. Zhong M. Fang Z. Guo W. Yu X. Translation regulatory long non‐coding RNA 1 negatively regulates cell radiosensitivity via the miR‐22‐3p/SP1 axis in non‐small cell lung cancer. Clin. Respir. J. 2024 18 1 e13734 e13734 10.1111/crj.13734 38286742
    [Google Scholar]
  89. Zhao X. Jin X. Zhang Q. Liu R. Luo H. Yang Z. Geng Y. Feng S. Li C. Wang L. Wang X. Li Q. Silencing of the lncRNA H19 enhances sensitivity to X-ray and carbon-ions through the miR-130a-3p /WNK3 signaling axis in NSCLC cells. Cancer Cell Int. 2021 21 1 644 644 10.1186/s12935‑021‑02268‑1 34863180
    [Google Scholar]
  90. Du R. Jiang F. Yin Y. Xu J. Li X. Hu L. Wang X. Knockdown of lncRNA X inactive specific transcript (XIST) radiosensitizes non-small cell lung cancer (NSCLC) cells through regulation of miR-16-5p/WEE1 G2 checkpoint kinase (WEE1) axis. Int. J. Immunopathol. Pharmacol. 2021 35 10.1177/2058738420966087 33583218
    [Google Scholar]
  91. Yu Z. Wang G. Zhang C. Liu Y. Chen W. Wang H. Liu H. LncRNA SBF2-AS1 affects the radiosensitivity of non-small cell lung cancer via modulating microRNA-302a/MBNL3 axis. Cell Cycle 2020 19 3 300 316 10.1080/15384101.2019.1708016 31928130
    [Google Scholar]
/content/journals/cctr/10.2174/0115733947339431241001080157
Loading
Long Non-coding RNAs: Potential Diagnostic and Treatment Targets for Non-small Cell Lung Cancer
Bentham Science Publishers ; https://doi.org/10.2174/0115733947339431241001080157
/content/journals/cctr/10.2174/0115733947339431241001080157
/content/journals/cctr/10.2174/0115733947339431241001080157
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: lncRNA ; Biomarker ; treatment ; diagnosis ; non-small cell lung cancer

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test